Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies

References

• Miller RG, Mitchell JD, Moore DH. Riluzole for amyotropic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2012;3:CD001447.
   PubMed Web of Science ®Google Scholar
• Kvemmo T, Harter S, Burger E. A review of the receptor binding and pharmacokinetic properties of dopamine agonists. Clin Ther 2006;28:1065–78.
   PubMed Web of Science ®Google Scholar
• DeBattista C, Solvason HB, Breen JA, Schatzberg AF. Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. J Clin Psychopharmacol 2000;20:274–5.
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Burdick KE, Endick CJ. Preliminary, randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment of resistant bipolar depression. Am J Psychiatry 2004;161:564–6.
   PubMed Web of Science ®Google Scholar
• Cassano P, Lattanzi L, Soldani F, et al. Pramipexole in treatment resistant depression on extended follow-up. Depression Anxiety 2004;20:131–8.
   PubMed Web of Science ®Google Scholar
• Sharma PC, Sinhmar A, Sharma A, et al. Medicinal significance of benzothiazole scaffold: an insight view. J Enzyme Inhib Med Chem 2013;28:240–66.
   PubMed Web of Science ®Google Scholar
• Nordqvist C. Inflammation: causes, symptoms and treatment. Medicinal News Today, 12; 2015. Available from: www.medicalnewstoday.com/articles/248423.php [last accessed 1 Mar 2017].
   Google Scholar
• Rostom A, Dube C, Wells G, et al. Prevention of NSAIDs induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002;4:CD002296.
   PubMedGoogle Scholar
• Lee A, Cooper MG, Craig JC, et al. Effects of NSAIDs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev 2007;2:CD002765.
   Google Scholar
• Royal Pharmaceutical Society of Great Britain. 5 Infections. British National Formulary 57. London: RPS Publishing; 2009.
   Google Scholar
• Caughey GF, Roughead EE, Pratt N, et al. Stroke risk and NSAIDs: an Australian population based study. Med J Australia 2011;195:525–9.
   PubMed Web of Science ®Google Scholar
• Varas-Lorenzo C, Rierra-Guardia N, Calingaert B, et al. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf 2011;20:1225–36.
   PubMed Web of Science ®Google Scholar
• Paramashivappa R, Phani KP, Subba Rao PV, Srinivasa RA. Design, Synthesis and Biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Lett 2003;13:657–60.
   PubMed Web of Science ®Google Scholar
• Kumar V, Sharma S, Hussain A. Synthesis and in vivo anti-inflammatory and analgesic activities of oxadiazoles clubbed with benzothiazole nucleus. Int Curr Pharm J 2015;4:457–61.
   Google Scholar
• Doma A, Kulkarmi R, Garlapati A, Krishna PR. Synthesis and anti-inflammatory activity of novel pyrimidino benzothiazole amine derivatives. Pharmacophore 2014;5:331–42.
   Google Scholar
• Sadhasivano G, Kulanthai K. Synthesis, characterisation and evaluation of anti-inflammatory and anti-diabetic activity of benzothiazole derivatives. J Chem Pharm Res 2015;7:425–31.
   Google Scholar
• Venkatesh P, Pandeya SN. Synthesis, characterisation and anti-inflammatory activity of some 2-aminobenzothiazole derivatives. Int J ChemTech Res 2009;1:1354–8.
   Google Scholar
• Gurupadyya B, Gopal M, Padmashali B, Manohara Y. Synthesis and pharmacological evaluation of azedidin-2-ones and thiazolidine-4-ones encompassing benzothiazole. Indian J Pharm Sci 2008;70:572–7.
   PubMed Web of Science ®Google Scholar
• Srivastava N, Salahuddin M, ShantaKumar S. Synthesis and anti-inflammatory activity of some novel 3-(6-substituted-1,3-benzothiazole-2-yl)-2-[((4-substituted phenyl)amino)methyl]quinazolinone-4-(3H)-ones. E-J Chem 2009;6:1055–62.
   Google Scholar
• Geronikaki A, Hadjipavlou-Litima D, Amourgianou M. Novel thiazolyl, thiazolinyl and benzothiazolyl Schiff bases as possible lipoxygenase’s inhibition and anti-inflammatory agents. Il Farmaco 2003;58:489–95.
   PubMedGoogle Scholar
• Shafi S, Alam MM, Mulakayala N, et al. Synthesis of novel 2-mercaptobenzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities. Eur J Med Chem 2012;49:324–333.
   PubMed Web of Science ®Google Scholar
• Ibrahim DA, Lasheen DS, Zaky MY, et al. Design, synthesis of benzothiazol-6-sulphonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem 2015;23:4989–99.
   PubMed Web of Science ®Google Scholar
• Kalina PH, Sheltar DJ, Lewis RA, et al. 6-Amino-2-benzothiazole-sulphonamide: the effect of a topical carbonic anhydrase inhibitor on aqueous humour formation in the normal human eye. Ophthalmology 1988;95:772–7.
   PubMed Web of Science ®Google Scholar
• Jagtap VP, Jayachandran E, Sriranga T, Sathe BS. Synthesis and screening of some fluoro substituted sulphonamide benzothiazole comprising quinazolines for anti-inflammatory activity. J Pharm Res 2011;4:4230–3.
   Google Scholar
• Argyropoulou I, Geronikaki A, Vicini P, Zani F. Synthesis and biological evaluation of sulphonamide thiazole and benzothiazole derivatives as antimicrobial agents. Arkivoc 2009;vi:89–102.
   Web of Science ®Google Scholar
• Bano S, Javed K, Ahmad S, et al. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzenesulphonamide moiety as potential anti-inflammatory and anticancer agent. Eur J Med Chem 2011;46:5763–8.
   PubMed Web of Science ®Google Scholar
• Ugwu DI, Okoro UC, Ukoha PO, et al. Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide. Eur J Med Chem 2017;135:349–69.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HA, Al-Rashood KA, ElTahir KEH, Suddek GM. Synthesis of N-benzenesulphonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents. Eur J Med Chem 2014;80:416–22.
   PubMed Web of Science ®Google Scholar
• Vijaya Kumar SG, Mishra DN. Analgesic, anti-inflammatory, and ulcerogenic studies of meloxicam solid dispersion prepared with polyethylene glycol 6000. Methods Find Exp Clin Pharmacol 2006;28:419–22.
   PubMedGoogle Scholar
• Lee SH, Son MJ, Ju HK, et al. Dual inhibition of cyclooxygenase-2 and 5-lipoxygenase by deoxypodophyllotoxin in mouse bone marrow-derived mast cells. Biol Pharm Bull 2004;27:788.
   Web of Science ®Google Scholar
• Leighton GE, Johnson MA, Meecham KG, et al. Pharmacological profile of PD 117302, a selective k-opioid agonist. Br J Pharmacol 1987;92:915–22.
   PubMed Web of Science ®Google Scholar
• Karlgren M, Bergstrom CAS. How physicochemical properties of drug affect their metabolism and clearance. In: Wilson AGE, editor. New horizons in predictive drug metabolism and pharmacokinetics. 2015;49:1–26.
   Google Scholar
• McNally VA, Rajabi M, Gbaj A, et al. Design, synthesis and enzymatic evaluation of 6-bridged imidazolyluracil derivatives as inhibitors of human thymidine phosphorylase. J Pharm Pharmacol 2007;59:537.
   PubMed Web of Science ®Google Scholar
• Alumi Z, Belaidi S, Lanez T, Tchouar N. Structure activity relationship, QSAR modeling and drug-like calculations of TP inhibition of 1,3,4-oxadiazoline-2-thione derivatives. Int Lett Chem Phys Astron 2014;37:113–24.
   Google Scholar
• Petit J, Maurice N, Kaiser C, Maggiora G. Softening the rule of five – where to draw the line ? Bioorg Med Chem 2012;20:5343–51.
   PubMed Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615–23.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Abraham MH, Lee J, et al. Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 2002;19:1446–57.
   PubMed Web of Science ®Google Scholar